• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CADL
Held by 2 Gurus
Share

Candel Therapeutics, Inc. Stocks

$ 8.67Last Updated 28.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 631.28M

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%

Trending

29.10.2026 13:25

Nasdaq futures fell 1.3%: Alphabet's earnings report could halt the tech rally

29.10.2026 12:09

The AI boom increased Samsung's profits nearly ninefold. Why did its stock plummet?

29.10.2026 11:46

Morning Roundup: Alphabet Shares Plunge After Earnings Report; Marvell Prepares for a Mega Deal

29.10.2026 09:01

Boeing's stock has fallen 23% since the start of the year. Is it worth buying on the dip?

29.10.2026 06:59

"Mega Deal": Marvell Is in Talks to Acquire Lumentum, a Developer of Data Center Optics

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026